147 related articles for article (PubMed ID: 33041341)
21. IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system.
Franca RF; Costa RS; Silva JR; Peres RS; Mendonça LR; Colón DF; Alves-Filho JC; Cunha FQ
J Neuroinflammation; 2016 Jun; 13(1):159. PubMed ID: 27334012
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung.
Faustino LD; Griffith JW; Rahimi RA; Nepal K; Hamilos DL; Cho JL; Medoff BD; Moon JJ; Vignali DAA; Luster AD
Nat Immunol; 2020 Nov; 21(11):1371-1383. PubMed ID: 32989331
[TBL] [Abstract][Full Text] [Related]
23. Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
Jo S; Kim E; Kwak A; Lee J; Hong J; Lee J; Youn S; Bae S; Kim B; Ryoo S; Kang TB; Her E; Choi DK; Kim YS; Lee Y; Jhun H; Kim S
Cytokine; 2016 Jul; 83():33-40. PubMed ID: 27031441
[TBL] [Abstract][Full Text] [Related]
24. Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.
Vasseur P; Dion S; Filliol A; Genet V; Lucas-Clerc C; Jean-Philippe G; Silvain C; Lecron JC; Piquet-Pellorce C; Samson M
Oncotarget; 2017 Jul; 8(30):48563-48574. PubMed ID: 28611297
[TBL] [Abstract][Full Text] [Related]
25. IL-33/ST2 contributes to severe symptoms in Plasmodium chabaudi-infected BALB/c mice.
Seki T; Obata-Ninomiya K; Shimogawara-Furushima R; Arai T; Akao N; Hoshino T; Ohta N
Parasitol Int; 2018 Feb; 67(1):64-69. PubMed ID: 28359899
[TBL] [Abstract][Full Text] [Related]
26. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
[TBL] [Abstract][Full Text] [Related]
27. miR-487b mitigates allergic rhinitis through inhibition of the IL-33/ST2 signaling pathway.
Liu HC; Liao Y; Liu CQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8076-8083. PubMed ID: 30556842
[TBL] [Abstract][Full Text] [Related]
28. T reg cell-intrinsic requirements for ST2 signaling in health and neuroinflammation.
Hemmers S; Schizas M; Rudensky AY
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33095261
[TBL] [Abstract][Full Text] [Related]
29. IL-33/ST2 axis promotes the inflammatory response of nasal mucosal epithelial cells through inducing the ERK1/2 pathway.
Li YQ; Zhong Y; Xiao XP; Li DD; Zhou Z; Tian YY
Innate Immun; 2020 Aug; 26(6):505-513. PubMed ID: 32456598
[TBL] [Abstract][Full Text] [Related]
30. IL33 (Interleukin 33)/ST2 (Interleukin 1 Receptor-Like 1) Axis Drives Protective Microglial Responses and Promotes White Matter Integrity After Stroke.
Xie D; Liu H; Xu F; Su W; Ye Q; Yu F; Austin TJ; Chen J; Hu X
Stroke; 2021 Jun; 52(6):2150-2161. PubMed ID: 33902297
[TBL] [Abstract][Full Text] [Related]
31. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy.
Liu B; Tai Y; Achanta S; Kaelberer MM; Caceres AI; Shao X; Fang J; Jordt SE
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7572-E7579. PubMed ID: 27821781
[TBL] [Abstract][Full Text] [Related]
32. [Research progress on the role of IL-33/ST2 axis in pathogenesis of allergic rhinitis].
Peng HS; Zhu XH
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):910-914. PubMed ID: 31623032
[No Abstract] [Full Text] [Related]
33. The IL-33/ST2 axis is specifically required for development of adipose tissue-resident regulatory T cells.
Hu ZQ; Zhao WH
Cell Mol Immunol; 2015 Sep; 12(5):521-4. PubMed ID: 26277897
[No Abstract] [Full Text] [Related]
34. Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
Eissmann MF; Dijkstra C; Wouters MA; Baloyan D; Mouradov D; Nguyen PM; Davalos-Salas M; Putoczki TL; Sieber OM; Mariadason JM; Ernst M; Masson F
Cancer Immunol Res; 2018 Apr; 6(4):409-421. PubMed ID: 29463593
[TBL] [Abstract][Full Text] [Related]
35. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.
Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB
Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter hepaticus infection-induced IL-33 promotes hepatic inflammation and fibrosis through ST2 signaling pathways in BALB/c mice.
Cao S; Zhu L; Zhu C; Feng J; Yin J; Lu J; Xu Y; Yang H; Huang Y; Zhang Q
Biochem Biophys Res Commun; 2020 May; 525(3):654-661. PubMed ID: 32122655
[TBL] [Abstract][Full Text] [Related]
38. IL-33 and the intestine: The good, the bad, and the inflammatory.
Hodzic Z; Schill EM; Bolock AM; Good M
Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
[TBL] [Abstract][Full Text] [Related]
39. IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.
Chen CC; Kobayashi T; Iijima K; Hsu FC; Kita H
J Allergy Clin Immunol; 2017 Nov; 140(5):1351-1363.e7. PubMed ID: 28196763
[TBL] [Abstract][Full Text] [Related]
40. The IL-33/ST2 pathway is not essential to Th2 stimulation but is key for modulation and survival during chronic infection with Schistosoma mansoni in mice.
Maggi L; Rocha IC; Camelo GMA; Fernandes VR; Negrão-Corrêa D
Cytokine; 2021 Feb; 138():155390. PubMed ID: 33341001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
